Across TCGA pan-cancer cohorts, FAM90A2P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated FAM90A2P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher FAM90A2P RNA is associated with better overall survival. In most high-consensus cancer types, elevated FAM90A2P expression acts as an unfavorable survival marker, although some lineages such as BRCA and LUSC show a favorable association.

BRCA, LUSC, and LGG are the cancer types where FAM90A2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Quartile	All	0.979	0.934	.002	53	view →
LUSC	DFS	Median	All	0.738	0.586	<.001	43	view →
LGG	DFS	Tertile	All	0.294	0.509	<.001	38	view →
KIRC	OS	Tertile	II,III,IV	0.412	0.653	.002	38	view →
BLCA	DFS	Median	All	0.573	0.464	.019	29	view →
UVM	OS	Median	II,III,IV	0.718	0.956	.002	24	view →
ESCA	DFS	Median	All	0.414	0.584	.005	21	view →
UCS	OS	Median	IV	0.844	0.234	.005	18	view →
CESC	DFS	Median	All	0.423	0.652	.007	16	view →
THYM	OS	Quartile	II,III,IV	0.726	1.000	.014	15	view →
SKCM	OS	Median	III,IV	0.802	0.608	.004	12	view →
ACC	OS	Median	II,III,IV	0.844	0.449	.016	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

Exploration

Same gene, other analysis: FAM90A2P tumor-vs-normal RNA expression · all FAM90A2P data types